MANGANESE Drug Patent Profile
✉ Email this page to a colleague
When do Manganese patents expire, and when can generic versions of Manganese launch?
Manganese is a drug marketed by Fresenius Kabi Usa, Hospira, and Abraxis Pharm. and is included in three NDAs.
The generic ingredient in MANGANESE is manganese sulfate. There are five drug master file entries for this compound. Additional details are available on the manganese sulfate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MANGANESE?
- What are the global sales for MANGANESE?
- What is Average Wholesale Price for MANGANESE?
Summary for MANGANESE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Drug Prices: | Drug price information for MANGANESE |
| What excipients (inactive ingredients) are in MANGANESE? | MANGANESE excipients list |
| DailyMed Link: | MANGANESE at DailyMed |
US Patents and Regulatory Information for MANGANESE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | MANGANESE CHLORIDE | manganese chloride | INJECTABLE;INJECTION | 217583-001 | Jul 7, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hospira | MANGANESE CHLORIDE IN PLASTIC CONTAINER | manganese chloride | INJECTABLE;INJECTION | 018962-001 | Jun 26, 1986 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Abraxis Pharm | MANGANESE SULFATE | manganese sulfate | INJECTABLE;INJECTION | 019228-001 | May 5, 1987 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
